Theralase Technologies Inc. (TLTFF)
USD 0.15
(4.23%)
USD 0.15
(4.23%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.07 Million CAD | -6.0% |
| 2022 | 1.13 Million CAD | 45.85% |
| 2021 | 780.64 Thousand CAD | -15.98% |
| 2020 | 929.12 Thousand CAD | -3.62% |
| 2019 | 964.05 Thousand CAD | -44.41% |
| 2018 | 1.73 Million CAD | -25.97% |
| 2017 | 2.34 Million CAD | 22.08% |
| 2016 | 1.91 Million CAD | -1.35% |
| 2015 | 1.94 Million CAD | 40.9% |
| 2014 | 1.38 Million CAD | 14.7% |
| 2013 | 1.2 Million CAD | -34.02% |
| 2012 | 1.82 Million CAD | -10.0% |
| 2011 | 2.02 Million CAD | -0.66% |
| 2010 | 2.04 Million CAD | -13.53% |
| 2009 | 2.35 Million CAD | 8.83% |
| 2008 | 2.16 Million CAD | 39.01% |
| 2007 | 1.55 Million CAD | 8.53% |
| 2006 | 1.43 Million CAD | 19.09% |
| 2005 | 1.2 Million CAD | 83.6% |
| 2004 | 657.35 Thousand CAD | 2271.23% |
| 2003 | 27.72 Thousand CAD | 1067.24% |
| 2002 | 2375.00 CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 175.55 Thousand CAD | -51.72% |
| 2024 Q2 | 100.84 Thousand CAD | -42.55% |
| 2023 Q4 | 363.61 Thousand CAD | 29.58% |
| 2023 Q1 | 207.16 Thousand CAD | -36.37% |
| 2023 FY | 1.07 Million CAD | -6.0% |
| 2023 Q2 | 218.92 Thousand CAD | 5.68% |
| 2023 Q3 | 280.6 Thousand CAD | 28.17% |
| 2022 Q4 | 325.57 Thousand CAD | 24.95% |
| 2022 Q2 | 340.78 Thousand CAD | 61.0% |
| 2022 Q3 | 260.55 Thousand CAD | -23.54% |
| 2022 Q1 | 211.66 Thousand CAD | -1.01% |
| 2022 FY | 1.13 Million CAD | 45.85% |
| 2021 Q2 | 305.21 Thousand CAD | 144.6% |
| 2021 FY | 780.64 Thousand CAD | -15.98% |
| 2021 Q4 | 213.82 Thousand CAD | 56.29% |
| 2021 Q3 | 136.81 Thousand CAD | -55.18% |
| 2021 Q1 | 124.78 Thousand CAD | -68.93% |
| 2020 FY | 929.12 Thousand CAD | -3.62% |
| 2020 Q3 | 234.02 Thousand CAD | 28.65% |
| 2020 Q2 | 181.91 Thousand CAD | 63.09% |
| 2020 Q1 | 111.54 Thousand CAD | -75.17% |
| 2020 Q4 | 401.64 Thousand CAD | 71.63% |
| 2019 Q1 | 121.17 Thousand CAD | -73.51% |
| 2019 Q2 | 249.25 Thousand CAD | 105.69% |
| 2019 Q3 | 144.45 Thousand CAD | -42.05% |
| 2019 Q4 | 449.16 Thousand CAD | 210.93% |
| 2019 FY | 964.05 Thousand CAD | -44.41% |
| 2018 Q2 | 469.49 Thousand CAD | 6.42% |
| 2018 FY | 1.73 Million CAD | -25.97% |
| 2018 Q4 | 457.44 Thousand CAD | 25.0% |
| 2018 Q1 | 441.19 Thousand CAD | -55.36% |
| 2018 Q3 | 365.94 Thousand CAD | -22.06% |
| 2017 Q4 | 988.25 Thousand CAD | 192.8% |
| 2017 Q3 | 337.52 Thousand CAD | -33.73% |
| 2017 FY | 2.34 Million CAD | 22.08% |
| 2017 Q1 | 507.42 Thousand CAD | -28.75% |
| 2017 Q2 | 509.3 Thousand CAD | 0.37% |
| 2016 Q2 | 481.69 Thousand CAD | 17.07% |
| 2016 Q4 | 712.16 Thousand CAD | 127.1% |
| 2016 Q3 | 313.58 Thousand CAD | -34.9% |
| 2016 FY | 1.91 Million CAD | -1.35% |
| 2016 Q1 | 411.44 Thousand CAD | -53.44% |
| 2015 Q2 | 309.51 Thousand CAD | -15.96% |
| 2015 FY | 1.94 Million CAD | 40.9% |
| 2015 Q1 | 368.3 Thousand CAD | -4.62% |
| 2015 Q4 | 883.63 Thousand CAD | 130.24% |
| 2015 Q3 | 383.79 Thousand CAD | 24.0% |
| 2014 Q3 | 134.03 Thousand CAD | -73.15% |
| 2014 Q2 | 499.25 Thousand CAD | 38.23% |
| 2014 Q1 | 361.17 Thousand CAD | 840.47% |
| 2014 FY | 1.38 Million CAD | 14.7% |
| 2014 Q4 | 386.13 Thousand CAD | 188.08% |
| 2013 FY | 1.2 Million CAD | -34.02% |
| 2013 Q4 | 38.4 Thousand CAD | -87.73% |
| 2013 Q3 | 313.02 Thousand CAD | -38.54% |
| 2013 Q2 | 509.29 Thousand CAD | 48.53% |
| 2013 Q1 | 342.9 Thousand CAD | 27.78% |
| 2012 Q4 | 268.35 Thousand CAD | -38.6% |
| 2012 Q1 | 448.35 Thousand CAD | -3.36% |
| 2012 Q2 | 670.53 Thousand CAD | 49.55% |
| 2012 FY | 1.82 Million CAD | -10.0% |
| 2012 Q3 | 437.06 Thousand CAD | -34.82% |
| 2011 Q4 | 463.92 Thousand CAD | 2.36% |
| 2011 Q1 | 421.31 Thousand CAD | -17.92% |
| 2011 Q2 | 688.6 Thousand CAD | 63.44% |
| 2011 Q3 | 453.21 Thousand CAD | -34.18% |
| 2011 FY | 2.02 Million CAD | -0.66% |
| 2010 Q2 | 640.27 Thousand CAD | 38.56% |
| 2010 Q4 | 513.3 Thousand CAD | 20.81% |
| 2010 FY | 2.04 Million CAD | -13.53% |
| 2010 Q1 | 462.08 Thousand CAD | -39.85% |
| 2010 Q3 | 424.87 Thousand CAD | -33.64% |
| 2009 Q4 | 768.21 Thousand CAD | 53.25% |
| 2009 Q1 | 461.37 Thousand CAD | -40.82% |
| 2009 Q2 | 629 Thousand CAD | 36.33% |
| 2009 Q3 | 501.26 Thousand CAD | -20.31% |
| 2009 FY | 2.35 Million CAD | 8.83% |
| 2008 Q4 | 779.6 Thousand CAD | 69.56% |
| 2008 Q1 | 324.02 Thousand CAD | -15.4% |
| 2008 Q2 | 604.99 Thousand CAD | 86.71% |
| 2008 Q3 | 459.78 Thousand CAD | -24.0% |
| 2008 FY | 2.16 Million CAD | 39.01% |
| 2007 Q2 | 431.13 Thousand CAD | 8.29% |
| 2007 FY | 1.55 Million CAD | 8.53% |
| 2007 Q3 | 347.58 Thousand CAD | -19.38% |
| 2007 Q4 | 382.99 Thousand CAD | 10.19% |
| 2007 Q1 | 398.14 Thousand CAD | 9.77% |
| 2006 Q2 | 413.41 Thousand CAD | 23.65% |
| 2006 FY | 1.43 Million CAD | 19.09% |
| 2006 Q3 | 326.79 Thousand CAD | -20.95% |
| 2006 Q4 | 362.7 Thousand CAD | 10.99% |
| 2006 Q1 | 334.34 Thousand CAD | -15.92% |
| 2005 Q2 | 311.29 Thousand CAD | 57.45% |
| 2005 FY | 1.2 Million CAD | 83.6% |
| 2005 Q4 | 397.63 Thousand CAD | 32.43% |
| 2005 Q1 | 197.7 Thousand CAD | -40.65% |
| 2005 Q3 | 300.27 Thousand CAD | -3.54% |
| 2004 FY | 657.35 Thousand CAD | 2271.23% |
| 2004 Q3 | 144.68 Thousand CAD | 138.75% |
| 2004 Q4 | 333.1 Thousand CAD | 130.22% |
| 2004 Q2 | 60.6 Thousand CAD | -49.06% |
| 2004 Q1 | 118.96 Thousand CAD | 355.92% |
| 2003 Q2 | 597.00 CAD | 10.97% |
| 2003 Q1 | 538.00 CAD | -3.06% |
| 2003 Q3 | 494.00 CAD | -17.25% |
| 2003 FY | 27.72 Thousand CAD | 1067.24% |
| 2003 Q4 | 26.09 Thousand CAD | 5181.98% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q4 | 555.00 CAD | -19.8% |
| 2002 Q3 | 692.00 CAD | 0.0% |
| 2002 FY | 2375.00 CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| IR-Med Inc. | - USD | -Infinity% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -49.754% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 62.011% |
| Polarean Imaging plc | 890.93 Thousand USD | -20.133% |
| Avitar, Inc. | 3.1 Million USD | 65.543% |
| AVITA Medical, Inc. | 50.56 Million USD | 97.883% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.864% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -1135.778% |
| QHSLab, Inc. | 1.4 Million USD | 24.038% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.864% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 97.966% |
| Escalon Medical Corp. | 11.98 Million USD | 91.067% |
| Aurora Spine Corporation | 14.52 Million USD | 92.629% |
| BrainsWay Ltd. | 31.78 Million USD | 96.633% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -315.816% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 98.437% |
| Vivos Inc. | 19.5 Thousand USD | -5388.754% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.887% |
| Kelyniam Global, Inc. | 2.67 Million USD | 59.949% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -425.387% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -1166.875% |
| Nanomix Corporation | 15.45 Thousand USD | -6827.553% |
| Theraclion SA | 1.82 Million USD | 41.264% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -61.788% |
| Positron Corporation | 734.66 Thousand USD | -45.686% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 20.648% |
| Lombard Medical, Inc. | 12.16 Million USD | 91.205% |
| ALR Technologies Inc. | 7468.00 USD | -14231.909% |
| Stratec SE | 289.14 Million USD | 99.63% |
| Vycor Medical, Inc. | 1.46 Million USD | 26.722% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -165.234% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 94.753% |
| VMS Rehab Systems, Inc. | 71.70 USD | -1492657.322% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -992.15% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -48.514% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 62.383% |
| Urologix, Inc. | 14.23 Million USD | 92.481% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 67.594% |
| SS Innovations International, Inc. | 5.87 Million USD | 81.797% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -2564.112% |
| Smith & Nephew plc | 5.68 Billion USD | 99.981% |
| NIOX Group Plc | 46.84 Million USD | 97.715% |
| Fuse Medical, Inc. | 16.11 Million USD | 93.359% |
| Broncus Holding Corporation | 10.25 Million USD | 89.563% |
| Brain Scientific Inc. | 214.56 Thousand USD | -398.829% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 45.883% |
| Health Logic Interactive Inc. | - USD | -Infinity% |